Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Disagree. Institutional buying will come strong with trial success. They will not give a hoot about share count but rather they do care about revenue potential, especially if we hit on AD. Apple, FB, MS, etc, float billions of shares and look where they are.
In any case, I think you and I are on the same page about our hope that the company succeds and handsomely rewards shareholders.
I do hope AVXL mints several millionaires/billionaires among their employees. Imagine what that would mean for you and I if we continue to hold. I know that is what I intend to do (hold) unless the narrative changes. I am happy with the CEO and what he has achieved so far. Granted, I would like him to be better at forecasting dates. This will be more relevant when forecasting financial metrics once comercial but we will worry about that in due time. I am hoping late 2021 early 2022.
Wishing the best for you.
Yes, i meant to write 1B float, 100B MC or hopefully higher. Tx for the correction.
My point is that if you own x shares the the value of your investment is not impacted by the number of options currently held with more to be granted, not matter the size. The PPS will raise/fall based on trial results; so hypothetically if the PPS gets to 100 on good results, does it matter to you if is based on 70 or 100M floated shares? It should not. The value of your holding will be x•100 regardless. I actually will not mind a 1M share float in the not too distant future, hopefully greatly impacted by forward split(s). This will create more liquidity to satisfy demand which will drive higher PPS.
Why worry about option grants. Options are awarded every year by most companies, even in years when the company’s performance has been sub par, and rarely have a negative impact on the PPS. They are only valuable if the share price is higher than the strike price.
My hope is that all Anavex’s option holders become extremely wealthy. It will do the same for us long-term share holders.
Voting yes. Not worried about dilution. The PPS will be 30, 40, 100, x, and my yyy,yyy shares will be worth time x. Dilution is more relevant when value is driving by revenue, earnings per share, not at this stage of development.
I trust Dr. M.
...as importantly, someone who is interacting with the trial patients on a regular basis is willing to join the company. He knows more than most of us the effect the drug is having and must believe that he is joining a winner, why else would he take that risk? Again, I believe this a significant positive event.
Thanks 3T.
For someone who has been so closely involved on ongoing trials to leave the comfort of a job he has held for many years can only point to a firm believe that the drug is working.
This to me is a very significant event. Great news coming soon! as Georgil reminds us daily.
“15 area is looking like resistance now”
Did we not have the same scenario with 2-4, 4-5, 5-6, 7-8, 9-10....
Will probably be the same all the way to $$$
But then again it might just go to $ again.
Love TA on companies with no revenues.
“Management isn't manipulating the stock or playing fantastical games of strategerization.”
You are exactly correct sir. Lots of BS conspiracy theories abound but in the end the only thing that matters is results from the ongoing trials. I am on the side of long-term success and PPS in line with big pharma numbers.
Agree.
What do you know? My opinion, not much about the topic.
Foolish statement.
I said no. I should have said it figures into P&L if you sell, AH that is.
I guess we are a society that needs to come up with conspiracy theories for any thing. One of the legacies from Mr. T.
AVXL is just finding its way to a SP more in line with the results of trials as it seats on the gold mine that is AD and other related deseases. Just enjoy the ride. Expect more bumps along the road but those too shall be overcome.
AVXL has already minted a few millionaires on this board. Hope you are one.
The discipline you exhibit with your trading strategy is commendable. Glad many here recognize it for what it really is.
By the tales you tell sounds like you are already a “made man” so this is all chump change for you.
Happy trading.
If they do a PR during market hours disclosing new material info, trading would be halted. SEC rules. Good thing for PPD in my opinion.
Filthy Freaking Rich and healthier with A 2-73 as a profylactic.
Apology given. My belief has been that 100-130 PPS would be a stretch. Your projection is more realistic based on the wide scope of diseases covered. Add a couple of splits to your 70k and you are looking at filthy richness.
"11.02 a.m LB25 - ANAVEX®2-73 (blarcamesine) Currently in Phase 2b/3 Early Alzheimer’s Disease (AD): Analysis of Cognitive Outcome
Measures Relevant in AD of Double-blind, Multicenter, Placebo-controlled Phase 2 Clinical Trial in 132 Patients with Parkinson’s
Disease Dementia
Dag Aarsland (1), Jaime Kulisevsky Bojarski (2), Mohammad Afshar (3), Coralie Williams (3), Frederic Parmentier (3), Martin
Kindermans (3), Tayo Fadiran (4), Andy Mattai (4), Christopher U Missling (4), Walter E Kaufmann (4)
(1)King’s College - London (United Kingdom); (2)University of Barcelona - Barcelona (Spain); (3)Ariana Pharma - Paris (France); (4)Anavex Life
Sciences - New York, NY (United States)"
The data must be quite compelling for Dr. M. to assemble this amazing panel of scientist and technicians, representing very prestigious institutions, to present at the premiere forum for AD about Parkinson's. The dots do connect in the myriad of CNS disorders so why not? In addition to the data I am sure there will be plenty of comentary about improvements in quality of life for those lucky participants not on placebo. This should once and for all put to bed any doubts that Anavex 2-73 is the real deal and it is destined to become the SOC for many of the CNS diseases, if not all, for which today there is very little hope for the expanding population of sufferers.
From the investment stand point I believe that from here forward upward is the trend, albeit with the usual pull backs. I have often thought some of the PPS projections by some of our fellow longs on this board were just pipe dreams. I no longer feel that way and expect that in the next 2-5 years Anavex will be one of the top pharmaceuticals in regards to market capitalization. The sky is the limit fellow longs.
Thanks TTT. Safe to assume that These updates to the trial would not be happening now if PDD results are not positive. Very encouraging. We soon will know for sure.
Agree. I am not suggesting to do this immediately. It all depends on good trial results. With that in the picture, there will be plenty of CEOS who would want to hitch their wagon to Anavex. Compensation would most likely be higher on the equity side rather than big salary. Need good trial results first. Without that, we will all be screwed.
We better get news tomorrow. Otherwise our CEO has failed shareholders again for overpromising and under delivering. While we will quickly forget that with good trial results, I do believe that we will benefit from moving Dr. M to preside over the board and bring onboard a seasoned CEO with experience running a commercial enterprise. Dr. M can then seat back and watch his net worth grow to the point of joining the Forbe’s annual list of billionaires. That would make us all happy campers as we would be able to get the baddest bike available and go cruising ala LSLeo.
Don’t agree with your premise. Deal and overdue data results are events independent of each other. Dr. M needs to deliver PDD results tomorrow to break his record of over promising and under delivering.
While I have lauded the Dr.’s efforts to bring the company this far, I also believe that we, shareholders, would benefit from a switch to a seasoned CEO with commercial experience and better marketing skills. Other than that Dr. M gets an A and moves to priside over the board and watch his net worth grow to the point that he makes Forbe's billionaires list. In any case, even if he does not deliver tomorrow, what matters most is positive trials results which we should learn about sooner or later. I am hoping for positive PR tomoroow. PPS will rocket into the teens by year-end.
Good find Bas. It is so obvious that the treatment is having positive results for the Dr. and patients to continue it after 5 years.
Who in their right mind would do that if it was otherwise.
All signs point to good results across all trials.
I believe any revenue is highly relevant. It validates the commercial value of the company. Obviously the biggest impact of Rett’s success would be the fact that the drug works and gives PDD and Alzheimer’s a higher probability.
Just my humble opinion.
Anavex Life Sciences Corp. (US:AVXL) has 164 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,724,962 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, IWM - iShares Russell 2000 ETF, State Street Corp, Knoll Capital Management, LP, Geode Capital Management, Llc, VEXMX - Vanguard Extended Market Index Fund Investor Shares, Northern Trust Corp, and Susquehanna International Group, Llp.
There will be a PR pre-market tomorrow. The Dr. will be quoted about what this means. 6+ share price easy.
That’s exactly my point.
If trial results, material info, are going to be discussed during cc, then there has to be an announcement pre-market. Else the stock trading will have to be halted for cc.
Anavex Alzheimer's Progress, And Other News: The Good, Bad And Ugly Of Biopharma https://seekingalpha.com/article/4352373
You mean horse pucky.
Absurd might be more appropriate.
Surprise, surprise, surprise!
Interesting observation that a stock that has outpaced the market in the last couple of months is doing it with little to no interest. Curious to hear your view as to when is a good time to invest, any stock.
Ask and you will get.
Thanks for the breaking news. A little late to the party perhaps?
Yeap. Predictable to the tune of ??7.5%. Drop in the bucket compare to what’s coming.